Peripheral ulcerative keratitis in a patient with granulomatous rosacea

A 24-year-old woman visited our emergency department due to intermittent dull pain in the right eye, blurred vision, foreign body sensation for 3 weeks, and progressive facial rash with pustules for 3 months. She had a history of recurring skin rash on her face and extremities since early adolescence. Peripheral ulcerative keratitis (PUK) was diagnosed based on slit-lamp examination and corneal topography and then granulomatous rosacea (GR) based on clinical manifestations and skin pathology. Topical prednisolone, artificial tears, oral doxycycline, oral prednisolone, and topical clindamycin were administered. After 1 month, PUK progressed to corneal perforation probably due to eye rubbing. The corneal lesion was repaired with a glycerol-preserved corneal graft. A dermatologist prescribed oral isotretinoin for 2 months in conjunction with topical betamethasone gradually tapered for 14 months. After 34 months of follow-up, no signs of skin and ocular recurrence were noted, and the cornea graft was intact. In conclusion, PUK may present with GR, and oral isotretinoin may be an effective therapy for PUK in the setting of GR.

[1]  M. Irkec,et al.  The effects of the systemic isotretinoin treatment on ocular surface and meibomian glands: a prospective longitudinal study , 2022, Cutaneous and ocular toxicology.

[2]  Jiayu Bao,et al.  Isotretinoin Impairs the Secretory Function of Meibomian Gland Via the PPARγ Signaling Pathway , 2022, Investigative ophthalmology & visual science.

[3]  Gomes Beatriz Fiuza,et al.  Biology of peripheral ulcerative keratitis. , 2021, Experimental eye research.

[4]  M. González-Gay,et al.  Biologic therapy in severe and refractory peripheral ulcerative keratitis (PUK). Multicenter study of 34 patients. , 2020, Seminars in arthritis and rheumatism.

[5]  B. Aksoy,et al.  Granulomatous Rosacea Histopathologically Confused with Papulonecrotic Tuberculid: A Case Report , 2017 .

[6]  Hongyan Zhou,et al.  Peripheral Ulcerative Keratitis Associated with Autoimmune Disease: Pathogenesis and Treatment , 2017, Journal of ophthalmology.

[7]  K. Sardana,et al.  Propionibacterium acnes and the Th1/Th17 Axis, Implications in Acne Pathogenesis and Treatment , 2017, Indian journal of dermatology.

[8]  T. Buhl,et al.  Molecular and Morphological Characterization of Inflammatory Infiltrate in Rosacea Reveals Activation of Th1/Th17 Pathways. , 2015, The Journal of investigative dermatology.

[9]  M. Zirwas,et al.  Granulomatous Rosacea and Periorificial Dermatitis: Controversies and Review of Management and Treatment. , 2015, Dermatologic clinics.

[10]  A. Di Nardo,et al.  Mast cells are key mediators of cathelicidin initiated skin inflammation in rosacea , 2014, The Journal of investigative dermatology.

[11]  M. Jordan,et al.  Diversity of IL-17-producing T lymphocytes , 2013, Cellular and Molecular Life Sciences.

[12]  T. Veiga-Parga,et al.  IL-17A Differentially Regulates Corneal Vascular Endothelial Growth Factor (VEGF)-A and Soluble VEGF Receptor 1 Expression and Promotes Corneal Angiogenesis after Herpes Simplex Virus Infection , 2012, The Journal of Immunology.

[13]  A. Borkowski,et al.  TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes. , 2011, The Journal of investigative dermatology.

[14]  Hiroshi Takayanagi,et al.  IκBζ regulates TH17 development by cooperating with ROR nuclear receptors , 2010, Nature.

[15]  P. Lehmann,et al.  Rosazea 2009 , 2009, Der Hautarzt.

[16]  R. Gallo,et al.  The molecular pathology of rosacea. , 2009, Journal of dermatological science.

[17]  R. Nurieva,et al.  Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. , 2009, Immunity.

[18]  N. Žarković,et al.  Oxidative stress and ferritin expression in the skin of patients with rosacea. , 2009, Journal of the American Academy of Dermatology.

[19]  C. Zouboulis,et al.  Isotretinoin: state of the art treatment for acne vulgaris , 2007, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[20]  Hilde Cheroutre,et al.  Reciprocal TH17 and Regulatory T Cell Differentiation Mediated by Retinoic Acid , 2007, Science.

[21]  T. Sorsa,et al.  Tear fluid levels of MMP-8 are elevated in ocular rosacea—treatment effect of oral doxycycline , 2006, Graefe's Archive for Clinical and Experimental Ophthalmology.

[22]  C. Creuzot-Garcher,et al.  Flow cytometric analysis of conjunctival epithelium in ocular rosacea and keratoconjunctivitis sicca. , 2000, Ophthalmology.

[23]  M. Dana,et al.  Twenty-five–Year Panorama of Corneal Immunology: Emerging Concepts in the Immunopathogenesis of Microbial Keratitis, Peripheral Ulcerative Keratitis, and Corneal Transplant Rejection , 2000, Cornea.

[24]  L. Sobrin,et al.  Regulation of MMP-9 activity in human tear fluid and corneal epithelial culture supernatant. , 2000, Investigative ophthalmology & visual science.

[25]  D. Easty,et al.  Role of ocular matrix metalloproteinases in peripheral ulcerative keratitis , 1999, The British journal of ophthalmology.

[26]  L. Sobrin,et al.  Tear fluid gelatinase B activity correlates with IL-1alpha concentration and fluorescein clearance in ocular rosacea. , 1999, Investigative ophthalmology & visual science.

[27]  Diane Thiboutot,et al.  Standard classification and pathophysiology of rosacea: The 2017 update by the National Rosacea Society Expert Committee , 2018, Journal of the American Academy of Dermatology.

[28]  M. Zemba,et al.  [Peripheral ulcerative keratitis]. , 2014, Oftalmologia.

[29]  B. Hazleman,et al.  Collagenase (MMP-1) and TIMP-1 in destructive corneal disease associated with rheumatoid arthritis , 1995, Eye.